"Ran, will AI replace my reps?"

I've been asked this question more times than I can count in the last 6 months. By VPs of Sales. By Country Managers. By reps themselves — quietly, after meetings, in elevators, on WhatsApp.

So let me break my habit of keeping the answer behind closed doors and put it on paper.

After 20 years in pharma and medtech commercial leadership, I'll tell you what I actually think. Not the safe answer. Not the keynote answer. The real one.

Half of today's pharma reps will be irrelevant by 2030. The other half will be more powerful than ever. Which one you are is a choice you're making this year.

Here's why.

The 70% of the job that's already gone

If your reps spend 70% of their week on admin and 30% on conversations — and most do — AI just made 70% of that job obsolete.

Today. Not in 5 years. Today.

If you're still paying $200K a year per rep for someone whose Monday is filled with Excel — you're not running a commercial organization. You're funding admin work in suits.

This isn't a threat. This is the relief reps have been waiting 20 years for.

What the dead pharma AI vendors got wrong

The graveyard is filling up. Aktana's quiet exit last October was the loudest funeral in the industry. But it won't be the last.

Aktana didn't fail because the team wasn't smart. They failed because recommending what to do next was never what reps actually needed. Reps need the work done.

Same for the rest of the dying playbooks:

None of these change the rep's day. They just add another tab.

What AI will NOT replace — and never will

I once watched a top-performing rep close a 5-year hospital contract over coffee. No slides. No data printout. She read the room — saw that the procurement director had just had a hard week, didn't push, and instead talked about his kids. They signed two months later.

I'd be lying if I told you AI can do that.

Pharma isn't selling widgets. It's selling trust, in a domain where the stakes are real — patient outcomes, regulatory consequences, professional reputation. The rep is the human face of a billion-dollar promise.

What AI can't replace:

This is the part of the job that has always mattered most. We just buried it under busywork.

The Augmented Rep wins. The others get replaced — by other reps.

The reps who will own the next 10 years aren't the reps with the deepest product knowledge. They're the reps who let AI do the 70%, and double down on the 30%.

Picture this:

The rep's job goes from execution-clerk to relationship-leader. From data-collector to judgment-maker.

The reps who refuse to use AI will be replaced. Not by AI. By reps who do.

Why we built Veraniqs the way we did

The temptation was always to build AI that tells reps what to do.

We're not building that. We're building the opposite — an Agentic Commercial Execution Platform (ACEP) that takes the strategic and operational work off the rep's plate, so the rep can do what only humans can do.

Two engines: Brainstorm (generates the strategic plan) and Execution (decomposes it into compliance-filtered actions per rep, per account, per day). 11 specialized agents under the hood. Strategy in. Action out.

The rep is still the one at the table, looking the HCP in the eye, building the trust that drives the prescription.

That's not me being optimistic about humans. That's me being realistic about pharma.

So — will reps exist in 10 years?

Yes. But not the ones who think "AI is just another tool."

The reps who treat AI as a co-pilot — and admin as the enemy — will own pharma's next decade.

The rest will explain to their kids why their job "just wasn't there anymore."

Imagine it. Describe it. Build it. The clock is already running. 🚀